False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences
Conclusions:
Pathologists and neuro-oncologists should be aware of false-positive 1p19q FISH results as they can significantly change treatment and prognosis for glioma patients. Moreover, this issue should be taken into account when designing clinical trials specific to this disease cohort.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Central Nervous System Source Type: research
More News: Brain | Brain Tumor | Cancer | Cancer & Oncology | Clinical Trials | Fish | Glioma | International Medicine & Public Health | Laboratory Medicine | Neurology | Pathology | WHO